一张关键图表:Moderna暴涨改写标普历史

投资观察
Aug 20

周三,Moderna股价一度飙升逾一倍,因该公司与默克联合开发的实验性mRNA癌症疫苗,在晚期临床试验中成功阻止黑色素瘤复发或扩散。这一高达177%的涨幅,不仅创下Moderna自身史上最大单日跃升纪录,也使其成为过去25年来标普500指数成分股中单日涨幅最大的个股——据道琼斯市场数据统计,如此惊人的表现实属罕见,足以载入史册。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10